Vecuronium block in the myasthenic patient. Influence of anticholinesterase therapy.
The neuromuscular block of vecuronium was investigated in two myasthenic patients undergoing thymectomy. The first patient had no pre-operative anticholinesterase therapy, the second patient was given pyridostigmine 60 mg 4 hourly, continued until the morning of surgery. In the two patients, neuromuscular block of vecuronium was monitored by electromyography. The results suggest that the neuromuscular block of vecuronium may be decreased by pre-operative preparation of the myasthenic patient by pyridostigmine.
Baraka
A
A
Department of Anesthesiology, American University of Beirut, Lebanon.
Taha
S
S
Yazbeck
V
V
Rizkallah
P
P
D000293:Adolescent; D000328:Adult; D000768:Anesthesia, General; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009407:Nerve Block; D009469:Neuromuscular Junction / Q000187:drug effects*; D011729:Pyridostigmine Bromide / Q000494:pharmacology / Q000627:therapeutic use*; D014459:Ulnar Nerve; D014673:Vecuronium Bromide / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D014673:Vecuronium Bromide; D011729:Pyridostigmine Bromide